Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Argus Health
AstraZeneca
McKinsey
Baxter
Farmers Insurance

Generated: July 18, 2019

DrugPatentWatch Database Preview

Drug Master Files for: dopamine

Try a free trialSee Plans and Pricing

« Back to Dashboard


dopamine Drug Master Files

DMF No. Status Type Submission Date Holder Subject
1063 I II 5/29/1967 CALBIOCHEM BEHRING CORP DOPAMINE HCL
1808 I II 8/24/1971 REGIS CHEMICAL CO 6-HYDROXYDOPAMINE (6-OHDA)
2453 I II 5/23/1975 WINTHROP PHARMACEUTICALS DIV STERLING DRUG INC DOPAMINE HYDROCHLORIDE
3060 I II 11/22/1977 KYOWA HAKKO KOGYO CO LTD L-DOPAMINE HYDROCHLORIDE (3-HYDROXYTYRAMINE HYDROCHLORIDE )
3116 A II 12/27/1977 SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH DOPAMINE HYDROCHLORIDE
4415 I II 1/20/1982 HOECHST CELANESE CORP DOPAMINE HCL, BULK DRUG SUBSTANCE
5134 A II 6/10/1983 RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA DOPAMINE HCl
DMF No. Status Type Submission Date Holder Subject

Subscribe to access the full database, or try a Free Trial


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Deloitte
Colorcon
Moodys
Baxter
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.